199 related articles for article (PubMed ID: 16722550)
1. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime.
Wood E; Tyndall MW; Lai C; Montaner JS; Kerr T
Subst Abuse Treat Prev Policy; 2006 May; 1():13. PubMed ID: 16722550
[TBL] [Abstract][Full Text] [Related]
2. Do supervised injecting facilities attract higher-risk injection drug users?
Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
[TBL] [Abstract][Full Text] [Related]
3. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime.
Freeman K; Jones CG; Weatherburn DJ; Rutter S; Spooner CJ; Donnelly N
Drug Alcohol Rev; 2005 Mar; 24(2):173-84. PubMed ID: 16076587
[TBL] [Abstract][Full Text] [Related]
4. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
[TBL] [Abstract][Full Text] [Related]
5. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
[TBL] [Abstract][Full Text] [Related]
6. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
Wood E; Tyndall MW; Zhang R; Montaner JS; Kerr T
Addiction; 2007 Jun; 102(6):916-9. PubMed ID: 17523986
[TBL] [Abstract][Full Text] [Related]
7. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
[TBL] [Abstract][Full Text] [Related]
8. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
[TBL] [Abstract][Full Text] [Related]
9. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
Fairbairn N; Small W; Shannon K; Wood E; Kerr T
Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
[TBL] [Abstract][Full Text] [Related]
10. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
[TBL] [Abstract][Full Text] [Related]
11. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
[TBL] [Abstract][Full Text] [Related]
12. Rationale for evaluating North America's first medically supervised safer-injecting facility.
Wood E; Kerr T; Montaner JS; Strathdee SA; Wodak A; Hankins CA; Schechter MT; Tyndall MW
Lancet Infect Dis; 2004 May; 4(5):301-6. PubMed ID: 15120347
[TBL] [Abstract][Full Text] [Related]
13. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.
Wood E; Kerr T; Tyndall MW; Montaner JS
Int J Drug Policy; 2008 Jun; 19(3):220-5. PubMed ID: 18551754
[TBL] [Abstract][Full Text] [Related]
14. Employment among users of a medically supervised safer injection facility.
Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T
Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450
[TBL] [Abstract][Full Text] [Related]
15. Condom use among injection drug users accessing a supervised injecting facility.
Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
[TBL] [Abstract][Full Text] [Related]
16. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
Andresen MA; Boyd N
Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
[TBL] [Abstract][Full Text] [Related]
17. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
[TBL] [Abstract][Full Text] [Related]
18. Access to health and social services for IDU: the impact of a medically supervised injection facility.
Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
[TBL] [Abstract][Full Text] [Related]
19. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
Wood E; Tyndall MW; Qui Z; Zhang R; Montaner JS; Kerr T
Am J Public Health; 2006 May; 96(5):770-3. PubMed ID: 16571703
[TBL] [Abstract][Full Text] [Related]
20. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.
Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T
AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
